(Total Views: 562)
Posted On: 09/16/2021 10:05:48 AM
Post# of 66
$PHIO News Article - Phio Pharmaceuticals Presents Data at ESMO 2021 Demonstrating Persistent Anti-Tumor Immunity with INTASYL Dual-Targeting PD-1 and BRD4 https://marketwirenews.com/news-releases/phio...04925.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
